Multi-country study provides a clear treatment option for IgA nephropathy

By | May 18, 2022
The largest ever randomized controlled trial in IgA nephropathy has found that treatment with methylprednisolone – a cheap, widely used corticosteroid drug – halves the risk of losing kidney function and kidney failure, and that this can be effectively achieved with fewer side effects if a reduced dose is used.